Altimmune Inc ALT

$ALT Here is the reason why a partnership would make more sense first… For the whole franchise though… We know more than one BP who would be happy to have Pemvi in their pipeline… We just need 1 BP stepping forward to launch a bidding war… Novo is shopping for liver disease molecules, Sanofi is evaluating a 4th therapeutical pillar, Lilly is looking for white spaces (AUD/ALD?) Merck is already working with a (successful?) Glucagon molecule, Gilead is a liver disease powerhouse, AstraZeneca building MASH capbilities without any MASH molecule in their pipeline… etc. I mean come on! Durso has to be worst salesman if he can’t close a descent deal in these conditions… He wouldn’t be able to sell a $5 water bottle to a thirsty billionaire in the middle of the desert…

$ALT Trying to look on the positive side -- they haven't in-licensed another drug candidate. That would spell GIA even longer IMO. Pemvi is the pipeline and the pipeline is pemvi. It's a clean setup for BP looking for a singular liver disease asset. It's just a matter of when the right price is agreed on, which is partly influenced by the market's share price. That's the conundrum.

$ALT what does everyone think the full BO price Durso and BOD would agree to? Akero type numbers? 89bio??

$ALT Durso net worth on searching is less than 4 million, salary is 725,000 from alt. To exercise his options he needs nearly 10 mil. That is only possible if Alt share price is significantly higher than where it is now. SIGNIFICANTLY HIGHER!

$ALT Perhaps this move to Morristown is connected to Alfasigma? They seem like a very scrappy / opportunistic organization. They are privately owned so Altimmune's market cap valuation gap isn't particularly important as it would be to a publicly traded BP. Interesting facts: -- They are currently hiring in the US. Most seem to be related to commercial execution, presumably related to Lynavoy, a recently FDA approved asset that was licensed from GSK earlier this year. However, several recently posted open positions are related to clinical trials / general pipeline development: https://alfasigmausa.com/careers/#careers-positions -- Vivek Devaraj was listed on Alfasigma's website on Sept. 25, 2026 (Wayback Machine) being listed as the President & Chairman of Alfasigma USA. Now he's nowhere to be found on the site. In his place, Melissa Leichter is featured as President, US Rare and Specialty Diseases. It is unknown when she joined, her LinkedIn still indicates she works at Novo Nordisk. IMO this indicates Alfasigma is segmenting their business, perhaps in the future adding President roles in other specialties. The connection to Novo is also interesting, but it doesn't appear she was involved on the GLP-1 portion of the business. -- They have a CDMO division (Morphos) that seems to be a fit for the packaging and cold chain logistics of a peptide like Pemvi, but probably not the manufacturing of the peptide. -- Stifel has an office in the same building as Alfasigma / Intercept (305 Madison). Not super relevant but kind of an interesting coincidence. I personally hope this is not the path forward, I don't think it would do much to improve Altimmune's SP in the immediate term. However it would provide Altimmune a secure path forward through additional clinical trials, provide commercial execution capabilities, and perhaps deliver LONG TERM shareholder value.

$ALT Ok I been back 3 days, had to wake up 4am each day to round and I still find time cuz I am nerdy like that to read the lines on Durso's grants. Not sure if ppl here posted it, and if they did, it certainly doesn't seem the DOOMERS and Durso haters here mentions it or knows it. Anyways, I am annoyed like everyone else here that a potential BO was nixed last year. But the payout could be a lot bigger now. But if you read the wording of Duro's rewards of options it is not free. 1) He is granted option to PURCHASE at $4.93 a total of 1,943,000 shares. 25% of which can be exercised 1yr from the date of this form which was 12/1/2025. Only 2 months now, at this share price he would be in the red on every option he exercise. To fully exercise he needs $9,578,990 2) Next wording is remaining 75% are dispersed monthly starting 12/1/2026 for the next 36months. Meaning like @TradeSun said, it is to his interest to maximize share price over the next 3 yrs and get pemvi to the FINISH line!

$ALT my breakeven MC is $2.4B…

$ALT Lol sorry y'all, that's the last of my ranting. Gonna go and forget about this for a bit and enjoy the weekend. Seems like every 3-4 months I do this to purge my frustrations 😂